{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:53:02Z","timestamp":1791604382558,"version":"4.3.4"},"reference-count":39,"publisher":"BMFH Press","issue":"4","funder":[{"name":"Liao Ning Revitalization  Talents Program","award":["XLYC1902072"],"award-info":[{"award-number":["XLYC1902072"]}]},{"name":"Basic Scientific  Research Program in Higher Education of Liaoning Province","award":["LJ212510163025"],"award-info":[{"award-number":["LJ212510163025"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.12938\/bmfh.2026-029","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:09:57Z","timestamp":1784239797000},"page":"272-283","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic effect of a naturally derived &lt;i&gt;Lactobacillus gasseri&lt;\/i&gt; and &lt;i&gt;Rumex hanus by.&lt;\/i&gt; extract on alleviating hyperuricemia in mice via uricolysis, gut microbiota modulation, and anti-inflammation"],"prefix":"10.12938","volume":"45","author":[{"given":"Ying-Ying","family":"SHENG","sequence":"first","affiliation":[{"name":"School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical              University, Wenhua Road 103, Shenyang 110016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hui","family":"LV","sequence":"additional","affiliation":[{"name":"School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical              University, Wenhua Road 103, Shenyang 110016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Liang","family":"ZHU","sequence":"additional","affiliation":[{"name":"The People\u2019s Hospital of Liaoning Province, Shenyang, Liaoning,              China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yue","family":"ZHANG","sequence":"additional","affiliation":[{"name":"School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical              University, Wenhua Road 103, Shenyang 110016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"LI","sequence":"additional","affiliation":[{"name":"Liaoning Beikri Biotechnology Co., Ltd., Shenyang, Liaoning,              China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Qiao","family":"XU","sequence":"additional","affiliation":[{"name":"Liaoning Beikri Biotechnology Co., Ltd., Shenyang, Liaoning,              China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Wei","family":"YANG","sequence":"additional","affiliation":[{"name":"Liaoning Beikri Biotechnology Co., Ltd., Shenyang, Liaoning,              China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Xu","family":"YU","sequence":"additional","affiliation":[{"name":"Liaoning Beikri Biotechnology Co., Ltd., Shenyang, Liaoning,              China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Xuan","family":"ZHANG","sequence":"additional","affiliation":[{"name":"School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical              University, Wenhua Road 103, Shenyang 110016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5076","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yip              K, Cohen              RE, Pillinger              MH. 2020.            Asymptomatic hyperuricemia: is it really            asymptomatic? Curr Opin Rheumatol 32:            71\u201379.","DOI":"10.1097\/BOR.0000000000000679"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Dalbeth              N, Gosling              AL, Gaffo              A, Abhishek              A. 2021.            Gout. Lancet 397:            1843\u20131855.","DOI":"10.1016\/S0140-6736(21)00569-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Li              X, Meng              X, Timofeeva              M, Tzoulaki              I, Tsilidis              KK, Ioannidis              JP, Campbell              H,                Theodoratou              E. 2017.            Serum uric acid levels and multiple health outcomes: umbrella review of            evidence from observational studies, randomised controlled trials, and Mendelian            randomisation studies. BMJ 357:            j2376.","DOI":"10.1136\/bmj.j2376"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pan              L, Han              P, Ma              S, Peng              R, Wang              C, Kong              W, Cong              L, Fu              J, Zhang              Z, Yu              H, et            al. 2020. Abnormal metabolism of gut            microbiota reveals the possible molecular mechanism of nephropathy induced by            hyperuricemia. Acta Pharm Sin B 10:            249\u2013261.","DOI":"10.1016\/j.apsb.2019.10.007"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Li              Q, Li              X, Wang              J, Liu              H, Kwong              JSW, Chen              H, Li              L, Chung              SC, Shah              A, Chen              Y, et            al. 2019. Diagnosis and treatment for            hyperuricemia and gout: a systematic review of clinical practice guidelines and            consensus statements. BMJ Open 9:            e026677.","DOI":"10.1136\/bmjopen-2018-026677"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Piani              F, Agnoletti              D, Borghi              C. 2023.            Advances in pharmacotherapies for hyperuricemia.            Expert Opin Pharmacother 24:            737\u2013745.","DOI":"10.1080\/14656566.2023.2197591"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Strilchuk              L, Fogacci              F, Cicero              AF. 2019.            Safety and tolerability of available urate-lowering drugs: a critical            review. Expert Opin Drug Saf 18:            261\u2013271.","DOI":"10.1080\/14740338.2019.1594771"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tsukagoshi              E, Tanaka              Y, Saito              Y. 2021.            Implementation of pharmacogenomic information on Stevens\u2013Johnson syndrome            and toxic epidermal necrolysis. Front Med            (Lausanne) 8: 644154.","DOI":"10.3389\/fmed.2021.644154"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. White              WB, Saag              KG, Becker              MA, Borer              JS, Gorelick              PB, Whelton              A, Hunt              B, Castillo              M,                Gunawardhana              L, CARES            Investigators2018. Cardiovascular safety of            febuxostat or allopurinol in patients with gout. N Engl J            Med 378: 1200\u20131210.","DOI":"10.1056\/NEJMoa1710895"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wang              J, Chen              Y, Zhong              H, Chen              F, Regenstein              J, Hu              X, Cai              L, Feng              F. 2022.            The gut microbiota as a target to control hyperuricemia pathogenesis:            potential mechanisms and therapeutic strategies. Crit Rev Food            Sci Nutr 62: 3979\u20133989.","DOI":"10.1080\/10408398.2021.1874287"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wang              Z, Li              Y, Liao              W, Huang              J, Liu              Y, Li              Z, Tang              J. 2022.            Gut microbiota remodeling: a promising therapeutic strategy to confront            hyperuricemia and gout. Front Cell Infect            Microbiol 12: 935723.","DOI":"10.3389\/fcimb.2022.935723"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wang              Q, Liang              J, Zou              Q, Wang              W, Yan              G, Guo              R, Yuan              T, Wang              Y, Liu              X, Liu              Z. 2024.            Tryptophan metabolism-regulating probiotics alleviate hyperuricemia by            protecting the gut barrier integrity and enhancing colonic uric acid            excretion. J Agric Food Chem 72:            26746\u201326761.","DOI":"10.1021\/acs.jafc.4c07716"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Ohtsu              T, Takagi              A, Uemura              N, Inoue              K, Sekino              H, Kawashima              A, Uchida              M, Koga              Y. 2017.            The ameliorating effect of <i>Lactobacillus gasseri<\/i> OLL2716            on functional dyspepsia in helicobacter pylori-uninfected individuals: a randomized            controlled study. Digestion 96:            92\u2013102.","DOI":"10.1159\/000479000"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Meng              Y, Hu              Y, Wei              M, Wang              K, Wang              Y, Wang              S, Hu              Q, Wei              H, Zhang              Z. 2023.            Amelioration of hyperuricemia by <i>Lactobacillus              acidophilus<\/i> F02 with uric acid-lowering ability via modulation of NLRP3            inflammasome and gut microbiota homeostasis. J Funct            Foods 111: 105903.","DOI":"10.1016\/j.jff.2023.105903"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zhou              Y, Zeng              Y, Wang              R, Pang              J, Wang              X, Pan              Z, Jin              Y, Chen              Y, Yang              Y, Ling              W. 2024.            Resveratrol improves hyperuricemia and ameliorates renal injury by            modulating the gut microbiota. Nutrients 16: 1086.","DOI":"10.3390\/nu16071086"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Vasas              A,                Orb\u00e1n-Gyapai              O, Hohmann              J. 2015.            The Genus <i>Rumex<\/i>: review of traditional uses,            phytochemistry and pharmacology. J            Ethnopharmacol 175: 198\u2013228.","DOI":"10.1016\/j.jep.2015.09.001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Piao              M, Wang              F, Shan              L, Deng              Y, Chen              T. 2022.              <i>Rumex hanus by.<\/i> extract protects against chronic            alcohol-induced liver injury in mice. J Med            Food 25: 751\u2013759.","DOI":"10.1089\/jmf.2021.K.0051"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Li              X, Ling              H, He              Z, Yang              Z, Jiang              T, Huang              P, Zeng              J. 2024.            Effects of edible grass (<i>Rumex patientia<\/i> L. \u00d7              <i>Rumex tianschanicus<\/i> A. LOS) Leaf powder on growth performance,            antioxidant properties, cecal short-chain fatty acids, and microbial community levels in            broilers. Antioxidants 13:            1291.","DOI":"10.3390\/antiox13111291"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Li              J, Wu              P, Wang              J, Meng              X. 2025.            Effective approaches to improve the anti-hyperuricemia ability of plant            polyphenols: a review. Food Rev Int 41: 749\u2013769.","DOI":"10.1080\/87559129.2024.2417944"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lu              J, Dalbeth              N, Yin              H, Li              C, Merriman              TR, Wei              WH. 2019.            Mouse models for human hyperuricaemia: a critical review.            Nat Rev Rheumatol 15:            413\u2013426.","DOI":"10.1038\/s41584-019-0222-x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ni              C, Li              X, Wang              L, Li              X, Zhao              J, Zhang              H, Wang              G, Chen              W. 2021.            Lactic acid bacteria strains relieve hyperuricaemia by suppressing            xanthine oxidase activity <i>via<\/i> a short-chain fatty acid-dependent            mechanism. Food Funct 12:            7054\u20137067.","DOI":"10.1039\/D1FO00198A"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Parveen              S, Tiwari              A, Ashraf              A. 2022.            Histology activity index: a benchmark for decision          making. Hepatol Int 16:            479\u2013479.","DOI":"10.1007\/s12072-021-10290-8"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Wang              S, Fang              Y, Yu              X, Guo              L, Zhang              X, Xia              D. 2019.            The flavonoid-rich fraction from rhizomes of <i>Smilax              glabra<\/i> Roxb. ameliorates renal oxidative stress and inflammation in uric acid            nephropathy rats through promoting uric acid excretion. Biomed            Pharmacother 111: 162\u2013168.","DOI":"10.1016\/j.biopha.2018.12.050"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Chiu              CJ, McArdle              AH, Brown              R, Scott              HJ, Gurd              FN. 1970.            Intestinal mucosal lesion in low-flow states. I. A morphological,            hemodynamic, and metabolic reappraisal. Arch            Surg 101: 478\u2013483.","DOI":"10.1001\/archsurg.1970.01340280030009"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Lu              P, Lin              D, Chen              N, Wang              L, Zhang              X, Chen              H, Ma              P. 2023.            CNN-assisted SERS enables ultra-sensitive and simultaneous detection of            Scr and BUN for rapid kidney function assessment. Anal            Methods 15: 322\u2013332.","DOI":"10.1039\/D2AY01573K"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Qin              Z, Wang              S, Lin              Y, Zhao              Y, Yang              S, Song              J, Xie              T, Tian              J, Wu              S, Du              G. 2018.            Antihyperuricemic effect of mangiferin aglycon derivative J99745 by            inhibiting xanthine oxidase activity and urate transporter 1 expression in            mice. Acta Pharm Sin B 8:            306\u2013315.","DOI":"10.1016\/j.apsb.2017.05.004"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Zhao              X, Cai              P, Xiong              S, Wei              B, Du              T, Huang              T, Yu              Q, Xie              M, Xiong              T. 2024.              <i>Lacticaseibacillus rhamnosus<\/i> NCUH061012 alleviates            hyperuricemia <i>via<\/i> modulating gut microbiota and intestinal metabolites            in mice. Food Biosci 58:            103699.","DOI":"10.1016\/j.fbio.2024.103699"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Zhao              X, Peng              F, Liu              Z, Peng              Z, Guan              Q, Cai              P, Xiong              S, Yu              Q, Xie              M, Xiong              T. 2023.            Lactic acid bacteria with anti-hyperuricemia ability: screening              <i>in vitro<\/i> and evaluating in mice. Food            Biosci 52: 102411.","DOI":"10.1016\/j.fbio.2023.102411"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Liang              L, Meng              Z, Zhang              F, Jianguo              Z, Fang              S, Hu              Q, Tang              X, Li              Y. 2023.              <i>Lactobacillus gasseri LG08<\/i> and <i>Leuconostoc              mesenteroides LM58<\/i> exert preventive effect on the development of            hyperuricemia by repairing antioxidant system and intestinal flora            balance. Front Microbiol 14:            1211831.","DOI":"10.3389\/fmicb.2023.1211831"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Zhao              Q, Liu              Y, Li              M, Zhao              L, Wang              T, Xiao              Y, Wei              S, Wu              K, Yang              J, Wang              Y, et            al. 2025. Hawthorn pectin mitigates            high-fat diet induced hyperlipidemia in mice through promoting <i>Dubosiella              newyorkensis<\/i>. Carbohydr Polym 359: 123570.","DOI":"10.1016\/j.carbpol.2025.123570"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Chen              YR, Jing              QL, Chen              FL, Zheng              H, Chen              LD, Yang              ZC. 2021.              <i>Desulfovibrio<\/i> is not always associated with adverse            health effects in the Guangdong Gut Microbiome Project.            PeerJ 9: e12033.","DOI":"10.7717\/peerj.12033"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. John              GK, Mullin              GE. 2016.            The gut microbiome and obesity. Curr Oncol            Rep 18: 45.","DOI":"10.1007\/s11912-016-0528-7"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Rysz              J, Franczyk              B, \u0141awi\u0144ski              J, Olszewski              R,                Cia\u0142kowska-Rysz              A,                Gluba-Brz\u00f3zka              A. 2021.            The impact of CKD on uremic toxins and gut microbiota.            Toxins (Basel) 13: 252.","DOI":"10.3390\/toxins13040252"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Keller              KL, Wall              JD. 2011.            Genetics and molecular biology of the electron flow for sulfate            respiration in desulfovibrio. Front Microbiol 2: 135.","DOI":"10.3389\/fmicb.2011.00135"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Hays              KE,                Pfaffinger              JM, Ryznar              R. 2024.            The interplay between gut microbiota, short-chain fatty acids, and            implications for host health and disease. Gut            Microbes 16: 2393270.","DOI":"10.1080\/19490976.2024.2393270"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Zhang              Y, Tu              S, Ji              X, Wu              J, Meng              J, Gao              J, Shao              X, Shi              S, Wang              G, Qiu              J, et            al. 2024. Dubosiella newyorkensis            modulates immune tolerance in colitis via the L-lysine-activated AhR-IDO1-Kyn            pathway. Nat Commun 15:            1333.","DOI":"10.1038\/s41467-024-45636-x"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Yang              J, Pu              J, Lu              S, Bai              X, Wu              Y, Jin              D, Cheng              Y, Zhang              G, Zhu              W, Luo              X, et            al. 2020. Species-level analysis of            human gut microbiota with metataxonomics. Front            Microbiol 11: 2029.","DOI":"10.3389\/fmicb.2020.02029"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Kuo              YW, Hsieh              SH, Chen              JF, Liu              CR, Chen              CW, Huang              YF, Ho              HH. 2021.              <i>Lactobacillus reuteri<\/i> TSR332 and <i>Lactobacillus              fermentum<\/i> TSF331 stabilize serum uric acid levels and prevent hyperuricemia            in rats. PeerJ 9:            e11209.","DOI":"10.7717\/peerj.11209"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Yang              B, Xin              M, Liang              S, Huang              Y, Li              J, Wang              C, Liu              C, Song              X, Sun              J, Sun              W. 2023.            Naringenin ameliorates hyperuricemia by regulating renal uric acid            excretion via the PI3K\/AKT signaling pathway and renal inflammation through the NF-\u03baB            signaling pathway. J Agric Food Chem 71: 1434\u20131446.","DOI":"10.1021\/acs.jafc.2c01513"}],"container-title":["Bioscience of Microbiota, Food and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/45\/4\/45_2026-029\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:27:30Z","timestamp":1791602850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/45\/4\/45_2026-029\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.12938\/bmfh.2026-029","relation":{},"ISSN":["2186-3342"],"issn-type":[{"value":"2186-3342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2026-029"}}